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et al., we observed no such age-dependent decrease 
in GFR (Fig. 1). Our results show a decrease in 
GFR (as estimated with the use of the Modifica-
tion of Diet in Renal Disease [MDRD] formula) 
after donation in all three age groups but with 
stable kidney function over the years. Our find-
ings support the conclusions of Ibrahim et al. and 
also indicate that kidney donation by older donors 
may be considered relatively safe over time, since 
kidney function does not appear to decline pro-
gressively.
Leonienke F.C. Dols, M.D. 
Willem Weimar, M.D., Ph.D. 
Jan N.M. IJzermans, M.D., Ph.D.
Erasmus Medical Center 
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The Authors Reply: Davis and Cooper note that 
the Minnesota donor cohort is almost entirely 
white, whereas in the United States as a whole, 86% 
of donors are white.1 They also comment on the 
ideal control group for kidney donors. As we note 
in our discussion, the ideal group would have been 
persons who were deemed suitable for donation 
but who did not donate. We compared the rate of 
incident ESRD among our donors with the rate 
among whites in the United States; most of our 
donors (>60%) are residents of Minnesota. In 2006, 
the rate of incident ESRD in Minnesota was al-
most identical to that in the rest of the country 
(359.8 and 363.2 cases per million, respectively). 
In previous years, the rate was 20 to 40 cases per 
million lower in Minnesota than in the rest of 
the country.2 We hope that the Renal and Lung 
Donors Evaluation (RELIVE) study (ClinicalTrials.
gov number, NCT00608283), which will report on 
more than 8000 kidney donors, with better mi-
nority representation and more comparable con-
trols, will address some of these concerns.
Freeman points out the critical finding that 
some donors had hypertension that was poorly 
controlled or undiagnosed. We strongly agree that 
there is a need to aggressively monitor and treat 
blood-pressure elevations in all kidney donors.
Ross and Thistlethwaite note that 3 of the 11 
donors in whom ESRD developed were nonwhite. 
One was a black woman, one an Asian woman, 
and one a Native American man. The Asian do-
nor had hypertension-related ESRD; the cause was 
unknown in the case of the other two. There were 
93 black donors, 39 Asian donors, and 76 Native-
American donors, yielding an incidence of ESRD 
of 1.1%, 2.6%, and 1.3%, respectively. Although 
the numbers are too small to draw conclusions, 
these data clearly indicate that race or ethnic back-
ground should be considered in the overall assess-
ment of risk, an area that our study could not 
fully address.
Dols et al. note that there was no age-related 
decline in GFR in their longitudinal studies of GFR 
in donors. We have measured GFR longitudi-
nally in 38 of our donors and noted a decline of 
0.59±3.84 ml per minute per year, a rate that is 
similar to that observed in our cross-sectional 
measurement of GFR. At the second GFR mea-
surement, GFR had decreased in 24 donors, had 
stayed the same in 2, and had actually risen in 
12, suggesting that a GFR decline with aging may 
not be universal.
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Minneapolis, MN 55414 
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A Surgical Safety Checklist
To the Editor: Haynes et al. (Jan. 29 issue)1 re-
port on a surgical safety checklist to reduce mor-
bidity and mortality in a global population. Trans-
ferring the concept of checklists from aviation to 
surgery sounds intuitively sensible. However, to 
claim that the use of checklists can reduce the 
perioperative rate of death by more than 30%, 
based on extrapolation across a mixture of hos-
pitals in developed and developing countries, may 
be misleading and counterproductive. In any case, 
all except one of the participating hospitals in 
developed countries had a preintervention rate of 
death that exceeded the published normal range 
of 0.4% to 0.8%. Indeed, the rate of death in the 
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only hospital at the extreme end of the normal 
range increased from 0.8% to 1.4% after the in-
tervention. 
In the United Kingdom, the National Patient 
Safety Agency has responded rapidly to this study 
by issuing a safety alert to all National Health 
Service hospitals; this alert requires the hospitals 
to use a modified 26-point checklist by 2010.2 
Although we support this initiative because it is 
likely to promote greater team cooperation, we are 
concerned that the implied reduction in the peri-
operative rate of death is unlikely to be realized 
in the United Kingdom, and ultimately, this may 
adversely affect credibility and compliance with 
this potentially valuable adjunct to safety mea-
sures for surgical patients.
Ian C. Martin, F.D.S.R.C.S., F.R.C.S. 
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George Findlay, F.R.C.A.
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To the Editor: Haynes and colleagues show the 
benefit of the surgical safety checklist for im-
proving perioperative care. Although the authors 
state that the intervention was neither “costly nor 
lengthy,” information to support this statement 
was not presented. The length of the checklist 
must be considered, especially for the anesthetized 
patient who is prone to physiological disturbance, 
including hypothermia. Thus, it is unclear why a 
“time out” should be conducted after the induc-
tion of anesthesia, rather than immediately before 
the induction of anesthesia (this is particularly im-
portant in lower-income environments with less 
availability of physiological support). The signifi-
cant benefits of education, checklist awareness, 
and increased resource utilization must be real-
ized. The adoption of increased use of antibiotics 
and pulse oximetry may have accounted for the 
survival advantage in lower-income sites. It is pos-
sible that implementation of other monitoring de-
vices, such as temperature monitoring, would fur-
ther improve perioperative care. However, although 
all sites in the current study had access to pulse 
oximetry and prophylactic antibiotics, the addition-
al costs associated with these resources were not 
disclosed. Many lower-income sites may lack fund-
ing for these resources.
Robert D. Sanders, M.B., B.S.
Imperial College London 
London SW10 9NH, United Kingdom 
robert.sanders@ic.ac.uk
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To the Editor: As reported by Haynes et al., the 
World Health Organization (WHO) Safe Surgery 
Saves Lives study shows strikingly large and im-
portant effects of checklists on the rates of inpa-
tient complications, including death. The use of 
checklists will be promoted globally.1 Unfortu-
nately, in addition to the weak preintervention–
postintervention design, the inference of effec-
tiveness is not convincing for other reasons. The 
Hawthorne effect is discussed as a possible mech-
anism of effect, rather than as a study limitation. 
Apart from consideration of the possible effects 
of direct observation in the operating room, oth-
er artifacts of the research process are not con-
sidered. Clinical teams were fully aware that they 
were participants in a study of their own behav-
ior. Surgical practice may well have been altered 
by this research context rather than by the check-
list. Blinding is recommended to reduce such per-
formance biases.2,3 Clinicians could have been kept 
unaware of the study, and the checklist could have 
been introduced as a matter of hospital policy in 
precisely the ways intended for subsequent routine 
use. The opportunity to reliably estimate the size 
of the effects of checklist introduction in a trial 
has been missed. Dedicated, sophisticated study 
of the Hawthorne effect is long overdue.4
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To the Editor: Haynes et al. discuss the benefi-
cial effects of using checklists for surgical proce-
dures. Many years ago, before attending medical 
school, I was a fighter pilot flying F-86 Sabrejets 
in the Air Force. I and most of my flying colleagues 
always used checklists that were strapped to our 
thighs while we were sitting in the cockpit. Every 
one of the myriad switches, gauges, dials, handles, 
and circuit breakers had to be properly set or 
checked. Procedures had to be followed assidu-
ously, especially during an emergency. Checklists 
helped us do that. Each of us knew that a careless 
mistake could lead to our death. By contrast, if 
physicians or nurses make a careless mistake, 
someone else suffers or dies. Many of us evince 
too cavalier an attitude in working with patients. 
If all of us in medicine thought our own lives were 
at risk, you can bet a lot fewer mistakes would be 
made. Requiring the use of checklists is an excel-
lent way to reduce errors and keep our patients 
safer.
David C. Levin, M.D.
Thomas Jefferson University Hospital 
Philadelphia, PA 19107 
david.levin@jeffersonhospital.org
The Authors Reply: Martin et al. express con-
cern that the rates of death in our study were not 
“normal” and that the beneficial results observed 
may therefore not be generalizable. We well recog-
nize that an eight-hospital study cannot provide a 
precise estimate of the magnitude of reduction in 
harm that is possible from broad implementation 
of the checklist. However, the larger criticism is 
flawed. The rates of death that we reported were 
for procedures conducted in the study operating 
rooms, not for hospital-wide procedures; the case 
mix varied widely among hospitals, and the hos-
pitals themselves had enormous diversity. In ad-
dition, the normal rate of postoperative death is 
unknown for the mix of cases observed in this 
international group of hospitals; a comparison with 
data from limited studies in developed countries 
would be invalid.
Sanders and Jameson correctly point out that 
the cost and time involved in such an intervention 
are important considerations. The checklist was 
designed to be brief; in testing, we aimed for a 
total duration of less than 2 minutes in routine 
situations, as shown in a training video provided 
to the study sites.1 The “time out” occurs after 
induction of anesthesia because it is not always 
practical to have the surgeon present before in-
duction. In addition, errors may be introduced in 
the period between the induction of anesthesia and 
skin incision, including incorrect draping and de-
lay of antibiotic administration. The cost of pro-
viding pulse oximetry and prophylactic antibiot-
ics is an important concern. However, the WHO 
recommends that these resources be used as 
minimum standards for safe surgery and that the 
value of elective surgery in their absence be criti-
cally examined.2 In clinical settings without ox-
imetry, as many as 1 in 150 patients has been re-
ported to have died from anesthesia-related causes,3 
and a surgical infection rate of more than 20% has 
been reported in settings without appropriate pro-
phylactic antibiotics.4
McCambridge et al. are legitimately concerned 
about the role observation may have played in the 
results. The precise cause-and-effect relationship 
between the checklist program and the observed 
reduction in complications is unclear. Observa-
tion could have produced a Hawthorne effect by 
three possible mechanisms. First, the presence 
of an observer may have affected outcomes, but, 
as noted, we found no such effect. Second, teams 
may have used the checklist more assiduously 
because of the ongoing study, but this would not 
weaken any checklist effect. Finally, there is the 
possibility that the performance of the operative 
teams improved because of their awareness of 
being studied. However, we would recommend 
that any attempt to implement the checklist in-
clude monitoring of basic surgical outcomes, re-
sulting in a similar scrutiny of results.
Levin astutely points out that lessons from avia-
tion can be applied to improve safety in health 
care. The design of the WHO checklist was in-
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formed by experience from aviation and other in-
dustries. The use of checklists enhances both pa-
tient safety and clinical professionalism.
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Asthma Induced by a Thermal Printer
To the Editor: Point-of-sale terminals are de-
vices used worldwide for credit-card or debit-card 
transactions or to print a variety of coupons. These 
machines print receipts on thermal paper cov-
ered with N-propyl-acrylamide and acrylate tints.
We report on a nonsmoking 62-year-old woman 
without atopy in whom asthma symptoms devel-
oped after she had worked for 20 years selling 
lottery tickets inside a 4-m3 kiosk. For the past 
3 years, she had been using a point-of-sale ter-
minal to print lottery tickets. She had a 2.5-year 
history of rhinoconjunctivitis, facial edema, cough, 
shortness of breath, and wheezing. These symp-
toms occurred within 30 to 60 minutes after she 
arrived at her workplace and diminished during 
days away from the workplace. She controlled the 
symptoms by using inhaled bronchodilators and 
pulses of oral corticosteroids. She required emer-
gency treatment on three occasions: 8, 6, and 
4 months before we examined her.
On evaluation at our clinic, there were no 
signs of atopy; baseline spirometric measure-
ments were normal, as was the fraction of ex-
haled nitric oxide (FeNO), at 14 ppb. The pro-
vocative concentration of inhaled methacholine 
required to reduce the forced expiratory volume 
in 1 second (FEV1) by 20% (PC20) was 6.18 mg 
per milliliter (normal value, >16.0 mg per milli-
liter). Patch tests that included several acrylates 
(Martí Tor) were negative. We performed a bron-
chial challenge in a 7-m3 chamber, as previously 
described.1 The patient painted on a cardboard 
for 30 seconds with the tint provided by the lot-
tery company, which contained trimethylolpro-
Table 1. Baseline Characteristics of the Patient and Results of Bronchial-Challenge Tests.*
Variable Baseline 
Placebo 
Challenge Bronchial Challenge 
Trimethylolpropane 
Triacrylate, 30 sec
Trimethylolpropane
Triacrylate, 90 sec
Printing Coupons, 
90 sec 
day 0 day 1 day 2 day 10
FEV1 1.96 liters (95% 
of predicted 
value)
No change for 
24 hr
19% decrease at 
30 sec 
45% decrease at 1 
min; no late asth-
matic reaction
15% decrease at 1 
min; no late asth-
matic reaction
Methacholine PC20 —  
mg/ml
6.2 ND 1.68 at 24 hr after 
challenge 
3.91 at 24 hr after 
challenge 
Eosinophil count in sputum 
— cells/ml (% of total 
cells)†
262,056 (7.2) ND 775,422 (18.7) at 24 
hr after challenge 
ND
FeNO — ppb 14 12 22 at 24 hr after chal-
lenge 
8 at 24 hr after chal-
lenge 
* FENO denotes the fraction of nitric oxide in exhaled air, FEV1 forced expiratory volume in 1 second, ND not done, and PC20 provocative 
concentration of inhaled methacholine.
† Sputum eosinophils were measured by means of flow cytometry. Data are from Sastre et al.2
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